Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging

Radiology

Volumn 210, Issue 3, 1999, Pages 769-774

  Miki, Yukio ^a   Grossman, Robert I ^a   Udupa, Jayaram K ^a   Van Buchem, Mark A ^a   Wei, Lougang ^a   Phillips, Michael D ^a   Patel, Upen ^a   McGowan, Joseph C ^a   Kolson, Dennis L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain, MR; Brain, white matter; Magnetic resonance (MR), magnetization transfer contrast; Sclerosis, multiple

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RATING SCALE; RELAPSE; REMISSION; WHITE MATTER;

EID: 0033008482     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.3.r99mr44769     Document Type: Article

References (53)

1. Jackson JA, Leake DR, Schneiders NJ, et al. Magnetic resonance imaging in multiple sclerosis: results in 32 cases. AJNR 1985; 6:171-176.
2. Jacobs L, Kinkel WR, Polachini I, Kinkel RP. Correlations of nuclear magnetic resonance imaging, computerized tomography, and clinical profiles in multiple sclerosis. Neurology 1986; 36:27-34.
3. Grossman RI, Yousem DM. White matter diseases. In: Thrall JH, ed. Neuroradiology: the requisites. St. Louis, Mo: Mosby, 1994; 201-224.
4. van der Knaap MS, Valk J. Multiple sclerosis. In: Magnetic resonance of myelin, myelination, and myelin disorders. 2nd ed. Berlin, Germany: Springer-Verlag, 1995; 296-313.
5. Ormerod IE, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987; 110:1579-1616.
6. Grossman RI, Braffman BH, Brorson JR, Goldberg HI, Silberberg DH, Gonzalez SF. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988; 169:117-122.
7. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatr 1991; 54:683-688.
8. Wallace CJ, Seland TP, Fong TC. Multiple sclerosis: the impact of MR imaging. AJR 1992; 158:849-857.
9. Paty DW, Li DK, Oger JJ, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994; 36 (suppl):95-96.
10. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995; 118:1601-1612.
11. The IFNB Multiple Sclerosis Study Group, The University of British Columbia MS/ MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995; 45:1277-1285.
12. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996; 39:6-16.
13. Wicks DA, Tofts PS, Miller DH, et al. Volume measurement of multiple sclerosis lesions with magnetic resonance images: a preliminary study. Neuroradiology 1992; 34:475-479.
14. Paty DW, Li DK. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group: interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43:662-667.
15. Mitchell JR, Karlik SJ, Lee DH, Fenster A. Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. JMRI 1994; 4:197-208.
16. Kamber M, Shinghal R. Model-based 3-D segmentation of multiple sclerosis lesions in magnetic resonance brain images. IEEE Trans Med Imaging 1995; 14:442-453.
17. Johnston B, Atkins MS, Mackiewich B, Anderson M. Segmentation of multiple sclerosis lesions in intensity corrected multispectral MRI. IEEE Trans Med Imaging 1996; 15:154-169.
18. Grimaud J, Lai M, Thorpe J, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996; 14:495-505.
19. Filippi M, Rovaris M, Campi A, Pereira C, Comi G. Semi-automated thresholding technique for measuring lesion volumes in multiple sclerosis: effects of the change of the threshold on the computed lesion loads. Acta Neurol Scand 1996; 93:30-34.
20. Filippi M, Miller DH. Magnetic resonance imaging in the differential diagnosis and monitoring of the treatment of multiple sclerosis. Curr Opin Neurol 1996; 9:178-186.
21. Matthews PM, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996; 119:715-722.
22. Udupa JK, Wei L, Samarasekera S, Miki Y, van Buchem MA, Grossman RI. Multiple sclerosis lesion quantification using fuzzy connectedness principles. IEEE Trans Med Imaging 1997; 16:598-609.
23. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-en-hancing magnetic resonance imaging lesions. Ann Neurol 1993; 33:480-489.
24. Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials. Ann Neurol 1994; 36 (suppl): 86-90.
25. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 1996; 119:2009-2019.
26. Miki Y, Grossman RI, Udupa JK, et al. Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification. AJNR 1997; 18:705-710.
27. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36:632-636.
28. Van Buchem MA, Udupa JK, McGowan JC, et al. Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR 1997; 18:1287-1290.
29. Simon JH, Schiffer RB, Rudick RA, Herndon RM. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. AJNR 1987; 8:599-604.
30. Rao SM, Leo GJ, Haughton VM, St Aubin FP, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39:161-166.
31. Pugnetti L, Mendozzi L, Motta A, et al. MRI and cognitive patterns in relapsing-remitting multiple sclerosis. J Neurol Sci 1993; 115(suppl):59-65.
32. Tsolaki M, Drevelegas A, Karachristianou S, Kapinas K, Divanoglou D, Routsonis K. Correlation of dementia, neuropsychological and MRI findings in multiple sclerosis. Dementia 1994; 5:48-52.
33. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-231.
34. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33:1444-1452.
35. Miki Y, Grossman RI, Udupa JK, et al. Isolated U-fiber involvement in MS: preliminary observations. Neurology 1998; 50:1301-1306.
36. McGowan JC, Schnall MD, Leigh JS. Magnetization transfer imaging with pulsed off-resonance saturation: variation in contrast with saturation duty cycle. JMRI 1994; 4:79-82.
37. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182:483-491.
38. Boorstein JM, Wong KT, Grossman RI, Bolinger L, McGowan JC. Metastatic lesions of the brain: imaging with magnetization transfer. Radiology 1994; 191:799-803.
39. Hiehle JJ, Grossman RI, Ramer KN, Gonzalez SF, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR 1995; 16:69-77.
40. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995; 196:511-515.
41. Kimura H, Grossman RI, Lenkinski RE, Gonzalez-Scarano F. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. AJNR 1996; 17:1539-1547.
42. Samarasekera S, Udupa JK, Miki Y, Wei L, Grossman RI. A new computer-assisted method for the quantification of enhancing lesions in multiple sclerosis. J Comput Assist Tomogr 1997; 21:145-151.
43. Udupa JK, Samarasekera S. Fuzzy connectedness and object definition: theory, algorithms and applications in image segmentation. Graphical Models Image Processing 1996; 58:246-261.
44. Udupa JK, Wei L, Samarasekera S, Miki Y, van Buchem MA, Grossman RI. Detection and quantification of MS lesions using fuzzy topological principles. SPIE Proc 1996; 2710:81-91.
45. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988; 111:927-939.
46. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. Arch Neurol 1992; 49:687-689.
47. Koopmans RA, Li DK, Grochowski E, Cutler PJ, Paty DW. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989; 25:74-81.
48. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990; 300: 631-634.
49. McDonald WI, Miller DH, Thompson AJ. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta (editorial). Ann Neurol 1994; 36:14-18.
50. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995; 132:222-227.
51. Filippi M, Campi A, Martinelli V, et al. A brain MRI study of different types of chronic-progressive multiple sclerosis. Acta Neurol Scand 1995; 91:231-233.
52. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43:2632-2637.
53. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119:701-708.